Title: Intravenous (IV) Ibuprofen Market Size and Share
1World Intravenous
(IV) Ibuprofen Market
Opportunities and Forecasts, 2015 2022
2Introduction of Intravenous Ibuprofon Market
Intravenous (IV) ibuprofen is a non-steroidal
anti-inflammatory drug (NSAID) used to reduce or
treat pain, fever, and inflammation occurred due
to a disease, operative procedures or trauma, and
acute illness. The intravenous (IV) route for
ibuprofen administration has a faster onset of
action as compared to the other routes. IV
ibuprofen is preferred for the management of
post-operative and acute pain. The demand for
ibuprofen has increased due to the side effects
of opioid analgesics such as respiratory
depression, allergic reactions, sedation, and
gastrointestinal events. The market for IV
ibuprofen for pain management is in its nascent
stage. The world IV ibuprofen market was valued
at 3.6 million in 2015, and is projected to
reach 14.2 million by 2022, registering a CAGR
of 20 during the forecast period. Advantages
associated with IV ibuprofen such as rapid
result and targeted drug delivery have resulted
in the growth of this market. In 2015, FDA
approved IV ibuprofen for pediatric use, due to
which the market is expected to register a
significant growth during the forecast period.
Other factors that affect the market growth
significantly include increasing incidence of
cancer, cardiovascular ailments, pain, headache,
toothache, back pain, arthritis, trauma, and
shifting trend towards the use of non-opioids
drugs. Factors that would hamper the market
growth include side effects associated with IV
ibuprofen and lengthy approval process.
3Introduction
Scope of
the Report
Key Benefits Key Audiences
4Key Benefits
Introduction to Smart Syringes Market
- This report provides an extensive analysis of the
current and emerging trends and dynamics in the
world IV Ibuprofen market. - The world IV Ibuprofen market is analyzed based
on countries such as the U.S., Australia, Canada
and South Korea. - The study evaluating competitive landscape has
been taken into account to - understand the competitive environment across the
countries considered. - This report provides detailed quantitative
analysis of the current market and estimations
from 2015 to 2022, which assists to identify the
prevailing opportunities. - Exhaustive analysis of the world IV Ibuprofen
market by indication describes - the types of indications that will gain
prominence in future.
Synthetic biology is a novel area of research
that is the amalgamation of multiple disciplines
such as molecular biology, biotechnology,
biophysics and genetic engineering among others.
There are chiefly two approaches used in
synthetic biology namely, top down approach and
bottom up approach. Top-down approach involves
the re-design and fabrication of existing
biological systems for producing synthetic
products. Bottom-up approach involves designing
and construction of de novo biological systems
or devices that do not exist in nature. World
synthetic biology market was valued at 5,245.7
million in 2015, growing at a CAGR of 23 during
the forecast period. Assistance from government
and private organizations, rising number of
synthetic biology research entities and declining
cost of DNA sequencing synthesizing are the
major factors driving the market growth. On the
contrary, bio-safety bio-security issues, would
hinder the market growth. The issues related to
the misuse of synthetic biology or possibilities
of accidental release of pathogens into free
atmosphere would remain as a key challenge
worldwide. However, rising demand for bio-fuels,
growing awareness in emerging economies and
rising RD investments for synthetic drugs and
vaccines would offer lucrative opportunities in
the market
5Table of Contents
- Introduction
- Executive Summary
- Market Overview
- World Intravenous Ibuprofen market, By Age Group,
2015-2022 - World Intravenous Ibuprofen Market, By
Indication, 2015-2022 - World Intravenous Ibuprofen Market, By Country,
2015-2022 - Company Profiles
- Enquiry about report at https//www.alliedmarketr
esearch.com/purchase-enquiry/1387
6World Intravenous Ibuprofen Market By Segments
KEY MARKET SEGMENTS
MARKET BY INDICATIONS
MARKET BY AGE GROUP
MARKET BY GEOGRAPHY
7Intravenous Ibuprofen Market Key
Introduction to Smart Syringes Market
Synthetic biology is a novel area of research
that is the amalgamation of multiple disciplines
such as molecular biology, biotechnology,
biophysics and genetic engineering among others.
There are chiefly two approaches used in
synthetic biology namely, top down approach and
bottom up approach. Top-down approach involves
the re-design and fabrication of existing
biological systems for producing synthetic
products. Bottom-up approach involves designing
and construction of de novo biological systems
or devices that do not exist in nature. World
synthetic biology market was valued at 5,245.7
million in 2015, growing at a CAGR of 23 during
the forecast period. Assistance from government
and private organizations, rising number of
synthetic biology research entities and declining
cost of DNA sequencing synthesizing are the
major factors driving the market growth. On the
contrary, bio-safety bio-security issues, would
hinder the market growth. The issues related to
the misuse of synthetic biology or possibilities
of accidental release of pathogens into free
atmosphere would remain as a key challenge
worldwide. However, rising demand for bio-fuels,
growing awareness in emerging economies and
rising RD investments for synthetic drugs and
vaccines would offer lucrative opportunities in
the market
Pain/Inflammatory
By Indications
Fever
8Intravenous Ibuprofen Market Key
Introduction to Smart Syringes Market
Synthetic biology is a novel area of research
that is the amalgamation of multiple disciplines
such as molecular biology, biotechnology,
biophysics and genetic engineering among others.
There are chiefly two approaches used in
synthetic biology namely, top down approach and
bottom up approach. Top-down approach involves
the re-design and fabrication of existing
biological systems for producing synthetic
products. Bottom-up approach involves designing
and construction of de novo biological systems
or devices that do not exist in nature. World
synthetic biology market was valued at 5,245.7
million in 2015, growing at a CAGR of 23 during
the forecast period. Assistance from government
and private organizations, rising number of
synthetic biology research entities and declining
cost of DNA sequencing synthesizing are the
major factors driving the market growth. On the
contrary, bio-safety bio-security issues, would
hinder the market growth. The issues related to
the misuse of synthetic biology or possibilities
of accidental release of pathogens into free
atmosphere would remain as a key challenge
worldwide. However, rising demand for bio-fuels,
growing awareness in emerging economies and
rising RD investments for synthetic drugs and
vaccines would offer lucrative opportunities in
the market
Pediatrics
By Age Groups
Adults
9Company Profiles
- Cumberland Pharmaceuticals Inc.
- Alveda Pharmaceuticals, Inc.
- CSL Limited, Sandor Medicaids Pvt Ltd.
- PT. Soho Industri Pharmasi
- Germin MED, Grifols S.A.
- Harbin Gloria Pharmaceuticals Co., Ltd.
- Al Nabeel International Ltd.
- Laboratorios Valmorca, C.A.
10Thank You!
For More Details
Visit us at
https//www.alliedmarketresearch.com/intravenous-
ibuprofen-market
Follow Us On